LI Yuanyuan, CHENG Hao, TANG Hao, et al. A Real World Study on Adjuvant Therapy of Shenqi Fuzheng Injection for Lung Cancer and Its Combined Medications[J]. Journal of Traditional Chinese Medicine2014, 55(12): 1063-1065.
LI Yuanyuan, CHENG Hao, TANG Hao, et al. A Real World Study on Adjuvant Therapy of Shenqi Fuzheng Injection for Lung Cancer and Its Combined Medications[J]. Journal of Traditional Chinese Medicine2014, 55(12): 1063-1065.DOI: 10.13288/j.11-2166/r.2014.12.020.
Objective To analyze the adjuvant therapy of Shenqi Fuzheng Injection( SFI) for lung cancer and its combined medications in the real world. Methods The medication information of SFI for 14
410 patients with lung cancer was collected from Hospital Information System( HIS) in 20 first class hospitals nationwide. Apriori algorithm was used to build model and Clementine 12. 0 was used to conduct correlation analysis. The complications of lung cancer
application of SFI and its combined medications were analyzed. Results In 14
410 patients
there were more men than women
most were aged or elderly( older than 46 years)
mostly with a single dose of SFI 250 ml( 99. 64%) and 1 to 3 day treatment( 63. 22%). Lung cancer was commonly accompanied by bone cancer
brain cancer
hypertension and diabetes. SFI was commonly combined with dexamethasone
promethazine
tropisetron
thymosin
ambroxol
Aidi Injection and Compound Kushen Injection. Conclusion SFI is usually combined with chemotherapy drugs
antineoplastic agents
tumor adjuvants
anti-gastrointestinal reaction drugs and immune modulators when treating lung cancer
mostly with a single dose of 250 ml and 1 to 3 day treatment.